Gori, Niccolo'
 Distribuzione geografica
Continente #
AS - Asia 944
NA - Nord America 745
EU - Europa 525
SA - Sud America 208
AF - Africa 32
OC - Oceania 3
Totale 2.457
Nazione #
US - Stati Uniti d'America 698
SG - Singapore 451
CN - Cina 252
BR - Brasile 173
DE - Germania 90
IT - Italia 82
SE - Svezia 69
FR - Francia 67
GB - Regno Unito 52
VN - Vietnam 49
IN - India 35
FI - Finlandia 34
ID - Indonesia 33
IE - Irlanda 31
CA - Canada 24
RU - Federazione Russa 24
HK - Hong Kong 23
KR - Corea 21
PL - Polonia 20
MX - Messico 17
IQ - Iraq 11
JP - Giappone 11
AR - Argentina 10
BD - Bangladesh 10
CI - Costa d'Avorio 10
NL - Olanda 10
PK - Pakistan 10
ZA - Sudafrica 10
SA - Arabia Saudita 9
AT - Austria 8
ES - Italia 8
BO - Bolivia 6
EC - Ecuador 6
KE - Kenya 6
MA - Marocco 5
TR - Turchia 5
VE - Venezuela 5
BE - Belgio 4
CZ - Repubblica Ceca 4
LT - Lituania 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
AU - Australia 3
CY - Cipro 3
PA - Panama 3
PE - Perù 3
PS - Palestinian Territory 3
PT - Portogallo 3
RO - Romania 3
UZ - Uzbekistan 3
CL - Cile 2
CO - Colombia 2
HR - Croazia 2
HU - Ungheria 2
IL - Israele 2
JO - Giordania 2
AZ - Azerbaigian 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
DK - Danimarca 1
DZ - Algeria 1
GD - Grenada 1
GY - Guiana 1
HN - Honduras 1
IR - Iran 1
JM - Giamaica 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
MY - Malesia 1
SY - Repubblica araba siriana 1
TM - Turkmenistan 1
UA - Ucraina 1
Totale 2.457
Città #
Singapore 224
Chandler 122
Ashburn 91
Beijing 59
Hefei 55
Frankfurt am Main 33
New York 32
Dublin 31
Jakarta 30
Los Angeles 30
Milan 25
Hong Kong 23
Helsinki 22
Munich 22
Ho Chi Minh City 21
Seoul 19
Dallas 18
Kent 18
Rome 18
London 17
Boston 16
Bremen 14
Moscow 13
Warsaw 13
Hangzhou 12
Princeton 12
São Paulo 12
Chicago 11
Abidjan 10
Amsterdam 10
Montreal 10
The Dalles 9
Brooklyn 8
Denver 8
Nuremberg 8
Roubaix 8
Stockholm 8
Tokyo 8
Boydton 7
Council Bluffs 7
Hanoi 7
Hyderabad 7
Curitiba 6
Lappeenranta 6
Manchester 6
Nairobi 6
Ottawa 6
Paris 6
Portsmouth 6
Pune 6
Redwood City 6
Santa Clara 6
Turku 6
Wilmington 6
Wroclaw 6
Boardman 5
Chennai 5
Falkenstein 5
Lauterbourg 5
Mexico City 5
Mumbai 5
Orem 5
Rio de Janeiro 5
San Mateo 5
Southampton 5
Vienna 5
Washington 5
Atlanta 4
Baghdad 4
Brussels 4
Düsseldorf 4
Johannesburg 4
La Paz 4
North Bergen 4
San Francisco 4
Toronto 4
Bexley 3
Chiyoda-ku 3
Cleveland 3
Haiphong 3
Indaiatuba 3
Jeddah 3
Nicosia 3
Panama City 3
Phoenix 3
Poplar 3
Porto Alegre 3
Querétaro 3
Quito 3
Redmond 3
Riyadh 3
Amman 2
Andover 2
Ansbach 2
Antakya 2
Barretos 2
Beachwood 2
Brasília 2
Brno 2
Busto Arsizio 2
Totale 1.365
Nome #
Assessment of alopecia areata universalis successfully treated with upadacitinib 111
Therapeutic impact and management of persistent head and neck atopic dermatitis in dupilumab-treated patients 108
Periocular molluscum contagiosum in an atopic dermatitis patient treated with upadacitinib 97
Dupilumab improves clinical manifestations, symptoms and quality of life in adult patients with chronic nodular prurigo 97
Biological agents targeting interleukin-13 for atopic dermatitis 96
Dupilumab-associated ocular adverse events are predicted by low tear break-up time and correlate with high IL-33 tear concentrations in patients with atopic dermatitis 93
Disease Severity Is Associated with Alexithymia in Patients with Atopic Dermatitis 88
Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real-life study 86
Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation 83
Successful Combination of Systemic Agents for the Treatment of Atopic Dermatitis Resistant to Dupilumab Therapy 81
Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: Data from the DA-COVID-19 registry 80
Head and neck atopic dermatitis: still a challenging manifestation in the biologic era 80
A case of disseminated perforating necrobiosis lipoidica 78
Effectiveness and Safety of Long-Term Dupilumab Treatment in Elderly Patients with Atopic Dermatitis: A Multicenter Real-Life Observational Study 75
Analysis of predictive factors influencing dupilumab continuation rate in adult patients with atopic dermatitis: results from an Italian multicenter study 74
Successful response of upadacitinib in different clinical phenotypes of atopic dermatitis 74
Histological features of immune cell infiltrate in lesional skin correlate with therapeutic response to dupilumab 68
Low grade of satisfaction related to the use of current systemic therapies among pustular psoriasis patients: a therapeutic unmet need to be fulfilled 67
Successful response to upadacitinib in the treatment of atopic dermatitis lesions involving sensitive and visible areas resistant to dupilumab treatment 66
Leser-Trélat sign as a rare manifestation of cutaneous melanoma 65
Comorbidities and treatment patterns in adult patients with atopic dermatitis: results from a nationwide multicenter study 63
Correction to: Comorbidities and treatment patterns in adult patients with atopic dermatitis: results from a nationwide multicenter study (Archives of Dermatological Research, (2022), 314, 6, (593-603), 10.1007/s00403-021-02243-w) 61
Evaluation of Upadacitinib efficacy in the treatment of Atopic Dermatitis of sensitive areas 60
Identification of clinical predictors for dupilumab dose spacing in adults with atopic dermatitis: a real-world study 60
Gianotti-Crosti Syndrome after SARS-CoV-2 infection 59
A case of guttate psoriasis during treatment with dupilumab 59
The psychological burden during COVID-19 pandemic in a cohort of patients affected by moderate-to-severe atopic dermatitis treated with dupilumab 58
Polymorphic Skin Eruption in a Middle-Aged Man: A Quiz 57
Association between maternal dupilumab exposure and pregnancy outcomes in patients with moderate-to-severe atopic dermatitis: A nationwide retrospective cohort study 56
Successful response to tralokinumab in patients unresponsive, intolerant or with contraindications to dupilumab and JAK inhibitors: A case series 54
Current treatment goals are achieved by the majority of patients with atopic dermatitis treated with tralokinumab: results from a multicentric, multinational, retrospective, cohort study 52
Response to the article by Narla et al “Management of inadequate response and adverse effects to dupilumab in atopic dermatitis” 50
Annular elastolytic giant cell granuloma following herpes zoster infection 48
National Information Campaign Revealed Disease Characteristic and Burden in Adult Patients Suffering from Atopic Dermatitis 41
Patient Satisfaction with Calcipotriol/Betamethasone Dipropionate Cream in Psoriatic Patients Previously Treated With Foam Vehicle 34
Use of upadacitinib in the treatment of moderate to severe atopic dermatitis: patient profiling, dose selection, and therapy modulation, what does real-life teach us? 21
Totale 2.500
Categoria #
all - tutte 13.062
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.062


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202123 0 0 0 0 0 2 1 12 0 1 6 1
2021/202271 2 0 0 3 4 2 4 6 0 7 18 25
2022/2023342 27 45 23 53 25 37 23 45 46 3 13 2
2023/2024311 14 41 47 29 23 38 23 7 11 8 39 31
2024/2025709 11 10 58 13 72 32 25 15 83 75 189 126
2025/20261.027 227 68 128 236 296 72 0 0 0 0 0 0
Totale 2.500